We are pleased to announce our latest news to you.
Nancy Meyerson-Hess about the benefits of patient engagement in R&D in the latest ClinicalTrialsArena article. Nancy Meyerson-Hess, BA, MPhil, discusses the benefits of patient engagement in R&D Patient engagement, a strong term, but what does it really mean?
We are very happy about welcoming Nancy Meyerson-Hess as a new Associate Partner of admedicum® Business for Patients.
Nancy Meyerson-Hess has over 30 years of experience in clinical research. She has led global teams of clinical research professionals within pharmaceutical and contract research organizations.
Dr. Andreas Reimann in an interview with Pharma Relations about patient orientation in pharmaceutical companies.
In the current edition of Pharma Relations 04/2017, the leading magazine for Pharma-Marketing and Healthcare Communication, Dr. Andreas Reimann talks about patient orientation in pharmaceutical companies.
Some key questions arising from the 2nd multi-stakeholder symposium on improving patient access to rare-disease therapies February 22 and 23, 2017, Brussels, Belgium
admedicum® Business for Patients regularly participates at discourses, workshops and conferences and thereby contributes the interaction between important stakeholders of the healthcare sector – constantly according to the patients´ needs!
Please find the information about upcoming events here:
Search the news
We gladly answer your questions concerning the contribution of admedicum® at the below mentioned events. Registration shall be submitted via the concerned organizers exclusively.